Specialty Practices

Handling GLP-1 Weight-Loss Inquiry Calls

How to handle GLP-1 weight-loss inquiry calls: program screening, honest cost and coverage answers, and consult booking without promising a prescription.

AssistCall research teamPublished Reviewed by Faruque Amin, VP of Sales and Marketing8 min read

On this page
  1. What these callers are asking
  2. The line the desk does not cross
  3. Cost questions, one part at a time
  4. Screening and booking the consult
  5. Setting expectations for the first visit
  6. Following up without pressure
  7. When the ad runs after hours
  8. Frequently asked questions
  9. References
Specialty Practices: Handling GLP-1 Weight-Loss Inquiry Calls12%: of US adults said they were currently taking a GLP-1 drug in late 2025SPECIALTY PRACTICESHandling GLP-1 Weight-LossInquiry Calls12%of US adults said they were currently taking a GLP-1 drug inlate 2025Ava Medical IntakeInsightsSpecialty Practices: Handling GLP-1 Weight-Loss Inquiry Calls12%: of US adults said they were currently taking a GLP-1 drug in late 2025SPECIALTY PRACTICESHandling GLP-1Weight-Loss InquiryCalls12%of US adults said they were currentlytaking a GLP-1 drug in late 2025Ava Medical Intake
Figure source: KFF, 2025[1]

Key takeaways

  • The desk never promises a prescription, a drug, a dose or a result. Eligibility is decided by the clinician at the consult[2].
  • Split cost into three parts: the visit or program, labs, and the medication. Only the first two are yours to quote.
  • Coverage for weight-loss use is patchy: 18% of large employers covered it in 2026[3], so say your team checks benefits after the consult.
  • Callers already on a compounded drug get booked and flagged for the clinician, not judged on the phone[4].

What these callers are asking

A weight-loss inquiry call usually packs three questions into the first sentence: can I get the shot here, will my insurance pay, and how soon can I start. The honest answers are “a clinician decides”, “it depends on your plan and why it's prescribed” and “here is our next consult”. None of them is the yes the caller hoped for, so the call is won or lost on how clearly and kindly the desk says them.

Demand is broad. In a KFF poll fielded in late 2025, 12% of US adults said they were currently taking a GLP-1 drug and 18% had taken one at some point; among adults who had never taken one, 22% said they would be interested in taking one to lose weight[1]. Obesity affected 40.3% of US adults in August 2021 to August 2023[5]. A practice that mentions weight management anywhere, from a website page to a short video, will hear from these callers.

Many have already shopped around. Of adults who had taken a GLP-1, 76% got it from one of their doctors, 17% from an online provider or website and 9% from a medical spa or aesthetic center[1]. Expect callers who quote a cash price from an online program and ask why your visit costs what it does, and callers already taking a compounded version who want you to take over.

Where GLP-1 users got the drugAdults who have taken a GLP-1 drug, by source, US, October to November 2025. Shares add to more than 100%.
Where GLP-1 users got the drugBar chart. One of their doctors: 76%; Online provider or website: 17%; Medical spa or aesthetic center: 9%.One of their doctorsOne of their doctors: 76%76%Online provider or websiteOnline provider or website: 17%17%Medical spa or aesthetic centerMedical spa or aesthetic center: 9%9%Where GLP-1 users got the drugBar chart. One of their doctors: 76%; Online provider or website: 17%; Medical spa or aesthetic center: 9%.One of their doctorsOne of their doctors: 76%76%Online provider or websiteOnline provider or website: 17%17%Medical spa or aesthetic centerMedical spa or aesthetic center: 9%9%

Source: KFF, 2025[1]

Show the data
SourceShare of users
One of their doctors76%
Online provider or website17%
Medical spa or aesthetic center9%

The line the desk does not cross

Write this rule where the phones are: the desk never promises a prescription, a specific drug or a dose, and never tells a caller they qualify. Eligibility is a clinical decision made at the visit. Staff should know why. FDA's 2023 approval of tirzepatide for chronic weight management covers adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol, alongside a reduced-calorie diet and more physical activity[2]. The clinician applies criteria like those, plus the patient's history. The desk's job is to get the right person to that consult with the right paperwork.

Example wording. Have your medical director approve the final version.
Caller saysDesk saysWhy
“Can you just prescribe Ozempic?”“Our clinicians decide on any medication at the consult, after reviewing your history. I can book that consult.”No promise of a drug or a brand
“Do I qualify? I'm about 40 pounds over.”“The clinician works that out with you at the visit. I can tell you what the visit includes.”Eligibility is a clinical call
“I'm on compounded semaglutide from an online clinic. Can you take over?”“Our clinician will review what you're taking. Please bring the pharmacy label and the dose.”The safety question goes to a clinician
“How much weight will I lose?”“That's a question for the clinician. Results differ from person to person.”No outcome claims
“Is it covered by my insurance?”“It depends on your plan and why it's prescribed. We check your benefits after the consult.”No coverage guesses

The compounded-drug call needs particular care. FDA says compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before they are marketed, and it had received 990 adverse event reports tied to compounded semaglutide and more than 730 tied to compounded tirzepatide as of May 31, 2026, some involving dosing errors[4]. The desk does not comment on the caller's source or tell them to stop. It books the consult, flags the call for the clinician and asks the caller to bring exactly what they are taking.

Cost questions, one part at a time

Cost is the question behind most of these calls, and it is three questions: what the visit or program costs, what labs cost, and what the medication costs. Separate them out loud. The first two your practice controls. The third depends on the plan, the pharmacy and the reason the drug is prescribed.

Coverage for weight loss is patchy. In KFF's 2026 employer survey, 18% of firms with 200 or more workers covered GLP-1 drugs used primarily for weight loss, from 16% of firms with 200 to 999 workers to 33% of firms with 5,000 or more, and 40% of covering firms required a dietitian, case manager, therapist or lifestyle program before the drug was covered[3]. Patients feel it: 56% of GLP-1 users said the drugs were difficult to afford, 27% of insured users paid the full cost themselves and 14% of users stopped because of cost[1].

GLP-1 costs, from the caller's side
  • 56%

    of GLP-1 users said the drugs were difficult to afford[1]

  • 27%

    of insured users paid the full cost themselves[1]

  • 14%

    of users stopped taking them because of cost[1]

  • 18%

    of firms with 200+ workers cover GLP-1s used for weight loss[3]

KFF Health Tracking Poll (October to November 2025) and KFF 2026 Employer Health Benefits Survey.

So the script avoids coverage promises in both directions. “Your plan probably won't pay” is as much a guess as “it should be covered”. Say what happens next instead: the clinician decides on treatment, then your team checks the benefits and handles any approval the plan requires. Callers who plan to pay cash should hear your self-pay prices for the visit and any program fee, and that a pharmacy sets the price of medication it fills.

Self-pay callers also have estimate rights. When an uninsured or self-pay patient schedules a service at least 3 business days ahead, the practice owes a good faith estimate within 1 business day of scheduling, and a patient who asks for one must get it within 3 business days of the request[6]. Build that into the booking step for cash-pay programs. The good faith estimate requirements and answering “how much will it cost?” cover the wording.

Screening and booking the consult

Screening at the desk means program fit, not medical eligibility. These questions decide which visit to book and what the caller should bring, and human staff ask them inside your normal intake process.

  1. Confirm program basics

    Age limits, whether visits are in person or by video, and for video visits which state the caller will be in, if your clinicians are licensed only in some states.

  2. Ask how they will pay

    Insurance or self-pay. Take the plan name from the card for a benefits check after the consult; give self-pay prices and the estimate notice.

  3. Ask whether they take one now

    Starting fresh or continuing a current prescription changes the visit type. The clinician decides how soon a continuing patient needs to be seen.

  4. Book the right visit type

    A new-patient weight management consult with the time the clinician needs, not a general new-patient slot.

  5. Send the prep list

    Recent lab results, a medication list, pharmacy labels for anything compounded and insurance cards, plus what the first visit includes and does not include.

  6. Log the source

    Website, ad, referral or a friend. It tells you which messages bring callers who actually book.

Example: a practice launching a weight management program fields 60 inquiry calls in its first month. The desk lead tags each one: 25 book a consult on the first call, 15 want a callback after checking their benefits, 12 are comparing prices with an online program, and 8 already take a compounded drug. The callback group gets a set call two business days later, and the compounded group is booked into the earliest consult and flagged for the clinician. The numbers are invented to show the tagging, not a benchmark.

Setting expectations for the first visit

Most disappointment in weight-management programs starts with a caller who expected to leave the first visit with a prescription. Tell them plainly what the visit is: a review of health history and current medicines, measurements, a discussion of options and, where the clinician thinks it fits, lab work. Options may include medication, nutrition support or other approaches, and the clinician decides with the patient.

Then explain the timeline after the visit. If a medication is prescribed and the patient is using insurance, the plan may need to approve it first, and some plans set conditions such as a lifestyle program: 40% of the large employers covering these drugs for weight loss in KFF's survey did[3]. Self-pay patients wait on the pharmacy instead. Either way, the start date is rarely the visit date, and a caller who hears that on day one is far less likely to call back upset on day five.

Example opening: “Thanks for calling about our weight management program. I can explain how the first visit works, what it costs if you're paying yourself, and how insurance questions are handled. Our clinicians decide on any medication at that visit, so I can't promise a prescription today, but I can get you in to see one.”

Following up without pressure

Inquiry callers who don't book on the first call are still deciding, and speed helps. Call back web-form inquiries the same business day. Expect voicemail: eight in ten US adults say they generally do not answer calls from unknown numbers[7], so leave a short message with the practice name and a direct number, and nothing about weight or medication. Speed to lead for patient inquiries has a callback schedule that works.

Keep follow-up factual. No before-and-after promises, no guaranteed results, no countdown offers on a prescription drug. Texts and emails carry consent and wording rules of their own, covered in marketing texts to patients. If you already run elective inquiries, the cosmetic consult lead process follows the same pattern.

When the ad runs after hours

Weight-loss inquiries arrive when people have time to think about them: evenings, lunch breaks, weekends, and right after an ad or a post. A practice that answers only from 8 to 5 loses many of those callers to a program with a web form and a chat box.

Example: a weight-management inquiry at 7:40 pm
  • Caller
  • SI Employee
  • Your team
  1. 01Caller

    Inquiry after work

    She read the practice's weight-management page and calls after work.

  2. 02SI Employee

    Greeting and notices

    Practice name, automated-assistant and recording notice, and the approved emergency line.

  3. 03SI Employee

    Answers approved facts

    Consult format, new-patient status, plans accepted and published self-pay prices.

  4. 04SI Employee

    No clinical questions

    It asks nothing about weight, conditions or medicines and never promises a prescription.

  5. 05SI Employee

    Callback request

    Name and callback number only, for the scheduling team in the morning.

  6. 06Your team

    Coordinator calls back

    Next morning the coordinator screens for program fit and books the consult.

Example flow. Booking into the practice's scheduling system is not part of this setup.

In that setup the SI Employee answers the program facts your practice approves, takes no health details, and leaves screening and booking to your coordinator. The family practice morning-rush example shows the same handoff for a primary care office, and what it does lists the current features.

Frequently asked questions

Can the front desk tell a caller they qualify for a GLP-1?

No. The clinician decides at the visit. FDA-approved weight-management uses have criteria based on BMI and weight-related conditions[2], and the clinician applies them alongside the patient's history.

What should we say to a caller already on compounded semaglutide?

Book the consult, flag the call for the clinician and ask them to bring the pharmacy label and dose. FDA notes compounded drugs are not FDA approved[4]; whether to switch or stop is a clinical conversation.

Will insurance cover GLP-1s for weight loss?

It depends on the plan and why the drug is prescribed. Among firms with 200 or more workers, 18% covered GLP-1s used primarily for weight loss in 2026[3], so the honest answer is that your team checks after the consult.

Do self-pay weight-loss patients get a good faith estimate?

Yes. For services scheduled at least 3 business days ahead it is due within 1 business day of scheduling, and on request within 3 business days[6].

How fast should we call back web inquiries?

The same business day. Leave a short voicemail with the practice name and a direct number, and nothing about weight or medication[7].

References

  1. KFF (2025). Poll: 1 in 8 adults say they are currently taking a GLP-1 drug, even as half say the drugs are difficult to afford (opens in a new tab) ↑

  2. U.S. Food and Drug Administration (2023). FDA Approves New Medication for Chronic Weight Management (opens in a new tab) ↑

  3. KFF (2026). 2026 Employer Health Benefits Survey (opens in a new tab) ↑

  4. U.S. Food and Drug Administration (2026). FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (opens in a new tab) ↑

  5. CDC National Center for Health Statistics (2024). Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023 (NCHS Data Brief No. 508) (opens in a new tab) ↑

  6. Legal Information Institute, Cornell Law School (eCFR text) (2026). 45 CFR 149.610: Good faith estimates for uninsured (or self-pay) individuals (opens in a new tab) ↑

  7. Pew Research Center (2020). Most Americans don't answer cellphone calls from unknown numbers (opens in a new tab) ↑

Book a demo

See Ava handle your calls.

Book a short demo. We’ll walk through your calls and workflow, and agree what Ava should take care of.

Book a demo